These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 36728420)

  • 1. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
    Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
    mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.
    Adeniji OS; Kuri-Cervantes L; Yu C; Xu Z; Ho M; Chew GM; Shikuma C; Tomescu C; George AF; Roan NR; Ndhlovu LC; Liu Q; Muthumani K; Weiner DB; Betts MR; Xiao H; Abdel-Mohsen M
    PLoS Pathog; 2021 Nov; 17(11):e1010034. PubMed ID: 34762717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Frequency of Dysfunctional Siglec-7
    Sakamoto Y; Yoshio S; Doi H; Mori T; Matsuda M; Kawai H; Shimagaki T; Yoshikawa S; Aoki Y; Osawa Y; Yoshida Y; Arai T; Itokawa N; Atsukawa M; Ito T; Honda T; Mise Y; Ono Y; Takahashi Y; Saiura A; Taketomi A; Kanto T
    Front Immunol; 2021; 12():603133. PubMed ID: 33692781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions.
    Capuano C; De Federicis D; Ciuti D; Turriziani O; Angeloni A; Anastasi E; Giannini G; Belardinilli F; Molfetta R; Alvaro D; Palmieri G; Galandrini R
    Front Immunol; 2023; 14():1285203. PubMed ID: 38045702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
    Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
    J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
    Comeau EM; Holder KA; Fudge NJ; Grant MD
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients.
    Hagemann K; Riecken K; Jung JM; Hildebrandt H; Menzel S; Bunders MJ; Fehse B; Koch-Nolte F; Heinrich F; Peine S; Schulze Zur Wiesch J; Brehm TT; Addo MM; Lütgehetmann M; Altfeld M
    Eur J Immunol; 2022 Aug; 52(8):1297-1307. PubMed ID: 35416291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19.
    Vietzen H; Danklmaier V; Zoufaly A; Puchhammer-Stöckl E
    Genet Med; 2022 Jul; 24(7):1449-1458. PubMed ID: 35488894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.
    Jia M; Li D; He X; Zhao Y; Peng H; Ma P; Hong K; Liang H; Shao Y
    Clin Exp Immunol; 2013 Jan; 171(1):107-16. PubMed ID: 23199330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
    Daly J; Carlsten M; O'Dwyer M
    Front Immunol; 2019; 10():1047. PubMed ID: 31143186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reduced frequency of natural killer cell on siglec-7(+) is associated with progression of hepatitis B virus-related cirrhosis].
    Li YL; Zhang QF; Yin WW; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):420-425. PubMed ID: 30317754
    [No Abstract]   [Full Text] [Related]  

  • 14. A Developed NK-92MI Cell Line with Siglec-7
    Huang CH; Liao YJ; Fan TH; Chiou TJ; Lin YH; Twu YC
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication.
    Zhao D; Jiang X; Xu Y; Yang H; Gao D; Li X; Gao L; Ma C; Liang X
    Front Immunol; 2018; 9():1124. PubMed ID: 29899741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection impairs NK cell functions
    Lenart M; Górecka M; Bochenek M; Barreto-Duran E; Szczepański A; Gałuszka-Bulaga A; Mazur-Panasiuk N; Węglarczyk K; Siwiec-Koźlik A; Korkosz M; Łabaj PP; Baj-Krzyworzeka M; Siedlar M; Pyrc K
    Front Immunol; 2023; 14():1123155. PubMed ID: 37287972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein.
    Chen X; Rostad CA; Anderson LJ; Sun HY; Lapp SA; Stephens K; Hussaini L; Gibson T; Rouphael N; Anderson EJ
    Virology; 2021 Jul; 559():1-9. PubMed ID: 33774551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
    Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
    Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
    Holder KA; Lajoie J; Grant MD
    Front Immunol; 2018; 9():2494. PubMed ID: 30483249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglec-7 Defines a Highly Functional Natural Killer Cell Subset and Inhibits Cell-Mediated Activities.
    Shao JY; Yin WW; Zhang QF; Liu Q; Peng ML; Hu HD; Hu P; Ren H; Zhang DZ
    Scand J Immunol; 2016 Sep; 84(3):182-90. PubMed ID: 27312286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.